McGill University Health Centre
Montreal, Quebec, H3A 2B4, Canada
Location status: Recruiting
NCT Number: NCT05025254
This is a feasibility and pilot study. Though large-scale online neurocognitive testing is increasingly being done in psychiatry, there are no such efforts in Parkinson's research. Thus a large part of this pilot study will be to demonstrate feasibility and reliability, and use this experience to develop a feasible protocol for ongoing research. The specific short-term objectives are:
1. To establish the feasibility of performing large-scale deep cognitive phenotyping using online cognitive testing. 2. To demonstrate that online neurocognitive testing is valid and reliable in a smaller sample of locally recruited participants tested both in-lab and online.
Interested in participating?
Request Info45 year–90 year
All sexes
Observational
Montreal, Quebec, H3A 2B4, Canada
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
We are assessing several cognitive domains and have made minor adaptations (reducing the total number of trials or lengthening response windows) to several standard neuropsychology tests including measures of executive function, working memory, visuospatial function, declarative memory, reward processing, response inhibition.
Overall, the tests we use follow a standard set-up: participants are shown stimuli on the screen and are asked to provide a response using either a keyboard or a mouse, based on a specific set of instructions. We always provide a detailed set of on-screen instructions and a practice phase. In some cases, information about performance is provided in the form of points, in other cases, none is provided.
Time frame: Measured once, as this is a cross-sectional study (time to complete cognitive tests is estimated to be 1.5 hours)
Proportion of registered participants who complete all the cognitive testing.
Time frame: Web-based and in-person testing will occur at two separate time points, at least 1 month apart and no more than 3 months apart
Intraclass correlation coefficient for web-based vs. in-person performance on the n-back test will be computed
Time frame: Web-based and in-person testing will occur at two separate time points, at least 1 month apart and no more than 3 months apart
Intraclass correlation coefficient for web-based vs. in-person performance on the Stroop test will be computed
Time frame: Web-based and in-person testing will occur at two separate time points, at least 1 month apart and no more than 3 months apart
Intraclass correlation coefficient for web-based vs. in-person performance on the Trail making test will be computed
Time frame: Web-based and in-person testing will occur at two separate time points, at least 1 month apart and no more than 3 months apart
Intraclass correlation coefficient for web-based vs. in-person performance on the image recognition test will be computed
Time frame: Web-based and in-person testing will occur at two separate time points, at least 1 month apart and no more than 3 months apart
Intraclass correlation coefficient for web-based vs. in-person performance on the probabilistic reward task will be computed
Contact information is provided by the study sponsor or research team.
McGill University
Other
Deep Cognitive Endophenotyping of Parkinson's Disease: A Platform Development and Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07207122
Basal Ganglia Diseases, Brain Diseases
Santa Monica, California, United States
View Trial DetailsNCT06680830
Basal Ganglia Diseases, Brain Diseases
Sun City, Arizona, United States
View Trial DetailsNCT07323121
Basal Ganglia Diseases, Brain Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT04477785
Anosmia, Basal Ganglia Diseases
Birmingham, Alabama, United States
View Trial Details